Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PHAS
3176
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $1.16M | ﹤0.01% |
189,717
+7,371
| +4% | +$30.4K |
|
|
YELL
3177
DELISTED
Yellow Corporation Common Stock
YELL
| $1.16M | ﹤0.01% |
454,335
+6,244
| +1% | +$21.4K |
|
3178
BioXcel Therapeutics
BTAI
$32.7M
| $1.16M | ﹤0.01% |
4,950
+1,081
| +28% | +$109K |
|
|
MBCN
3179
DELISTED
Middlefield Banc Corp
MBCN
| $1.15M | ﹤0.01% |
44,171
+1
| +0% | +$25 |
|
|
GCAP
3180
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $1.15M | ﹤0.01% |
291,140
+7,878
| +3% | +$33.9K |
|
3181
Spero Therapeutics
SPRO
$68.9M
| $1.15M | ﹤0.01% |
119,452
+2,670
| +2% | +$28.8K |
|
|
ADMS
3182
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.14M | ﹤0.01% |
300,457
+33,902
| +13% | +$162K |
|
3183
Purple Innovation
PRPL
$28.4M
| $1.14M | ﹤0.01% |
5,213
+4,524
| +657% | +$872K |
|
3184
Universal Technical Institute
UTI
$1.41B
| $1.13M | ﹤0.01% |
147,180
+27,606
| +23% | +$166K |
|
3185
KB Financial Group
KB
$41.4B
| $1.13M | ﹤0.01% |
27,343
+6,715
| +33% | +$257K |
|
|
NVMI
3186
Nova
NVMI
$12.9B
| $1.13M | ﹤0.01% |
29,933
+3,590
| +14% | +$126K |
|
3187
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.79B
| – | – |
0
| – | – |
|
|
GEN
3188
DELISTED
Genesis Healthcare, Inc.
GEN
| $1.13M | ﹤0.01% |
688,297
+23,585
| +4% | +$35.4K |
|
3189
LSI Industries
LYTS
$890M
| $1.13M | ﹤0.01% |
186,079
+1,110
| +0.6% | +$6.1K |
|
3190
Colony Bankcorp
CBAN
$467M
| $1.12M | ﹤0.01% |
68,032
+641
| +1% | +$10.1K |
|
|
GBL
3191
DELISTED
GAMCO Investors, Inc.
GBL
| $1.12M | ﹤0.01% |
57,373
+1,358
| +2% | +$23.9K |
|
3192
Stereotaxis
STXS
$139M
| $1.12M | ﹤0.01% |
+211,184
| New | +$839K |
|
3193
LSB Industries
LXU
$711M
| $1.12M | ﹤0.01% |
345,570
+12,507
| +4% | +$42.2K |
|
3194
Maui Land & Pineapple Co
MLP
$317M
| $1.11M | ﹤0.01% |
99,150
+262
| +0.3% | +$2.79K |
|
|
ATCX
3195
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $1.11M | ﹤0.01% |
110,000
+10,000
| +10% | +$101K |
|
3196
Ranpak Holdings
PACK
$464M
| $1.11M | ﹤0.01% |
+136,419
| New | +$873K |
|
|
SSI
3197
DELISTED
Stage Stores Inc
SSI
| $1.11M | ﹤0.01% |
136,736
-30,230
| -18% | -$117K |
|
|
ICBK
3198
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $1.1M | ﹤0.01% |
42,938
| – | – |
|
3199
Aclaris Therapeutics
ACRS
$860M
| $1.1M | ﹤0.01% |
581,183
+90,067
| +18% | +$149K |
|
|
LNAI
3200
Lunai Bioworks
LNAI
$10.7M
| $1.09M | ﹤0.01% |
2,725
+2,027
| +290% | +$891K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.